| Management/Advisory Committees |
 |
Management
Committee |
|
Comprised of the Vice-President
for Research and Development, the Dean of Science and the Director
of BRI, the Management Committee oversees the long term directions
and policy of the Institute. |
 |
International
Advisory Committee (IAC) |
|
The IAC's role is to
provide BRI with links to the international scientific community in
both academia and industry. The IAC advises BRI on the long term directions
of its research programs and reviews its progress and overall strategies.
Current members: |
| |
 |
Professor Wolf-Dieter Busse,
Chief Executive Officer, Aerovance, Inc. |
| |
 |
Dr. Colin R. Gardner, Chief
Scientific Officer, TransForm Pharmaceuticals, Inc. |
| |
 |
Professor Kuo-Hsiung Lee, Kenan Professor
of Pharmacy, The University of North Carolina at Chapel Hill |
| |
 |
Professor Eric M. Shooter,
Professor of Neurobiology, Stanford University |
| |
 |
Professor Daniel I. C. Wang, Institute
Professor of Chemical Engineering, Massachusetts Institute of Technology |
 |
Working
Group |
|
The Working Group is
comprised of HKUST faculty from the School of Science. It participates
in the Institute's wide array of activities, and lends support and
recommendations to the Director. |
| |
 |
Professor Yung Hou Wong (Chairman) |
| |
 |
Professor Zhenguo Wu (Vice-Chairman) |
| |
 |
Professor Nancy Y. Ip |
| |
 |
Professor Randy Y. C. Poon |
| |
 |
Professor Mingjie Zhang |
| |
|
| |
|